brazzein
Pre-clinical- Indications
- Diabetes
Company intelligence / Profile preview
Biofect Innovations
Toronto, Ontario, Canadabiofectinnovations.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Biofect Innovations is developing sustainable protein ingredients using microbial fermentation technology. Their lead product is brazzein, a sugar substitute, which they are currently scaling up for commercial production[3][4].
- Modalities
- Protein ingredientsSugar substitutes
- Industry
- Food & Nutrition
02
Drug pipeline
1 asset03
Partnerships
Creative Destruction LabBioCreate ProgramOntario GenomicsOntario Agri-Tech Pitch CompetitionProveg Incubator
Beyond the preview
Go deeper on Biofect Innovations.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biofect Innovations.